Seminar:Recovery, a clinical reality
Recovery, a clinical reality
Colin Bell Building, University of Stirling
This session will consider the re-appearance of "recovery" in the international debate around the treatment of substance use problems from the perspective of the clinical specialist. The session will consider the history of treatment in the UK – highlighting the drivers which have led to services being delivered with an ever stronger harm reduction emphasis. Strengths and weaknesses of these developments will be considered. The evolution of harm reduction from pragmatic medical intervention addressing the dangers of injecting drug use to (apparent) cure-all for every biological, social and psychological consequence of drug use will be discussed. Particular emphasis will be placed on replacement prescribing interventions – including consideration of the potential harms associated with long term opiate prescribing. The seminar will conclude by discussing current initiatives to move the debate forward.
Part of the Pathways to Recovery series. See: http://www.dass.stir.ac.uk/old-site/seminars/ for details.
Alex Baldacchino & Brian Kidd, 18th March 2009 – Dr Baldacchino is consultant psychiatrist and clinical senior lecturer in Addiction Psychiatry with NHS Fife and the University of Dundee . He has been researching co-morbid substance misuse and associated psychiatric and physical issues for the last 10 years. His studies involved biological, neuropsychological, clinical and policy related research. In the last 8 years he has been the UK Principal Investigator to several European Union funded projects. These include looking at barriers and challenges faced by individuals with substance misuse related problems accessing treatment (IATPAD Study), a cross-cultural multicentre study to determine the nature, extent and management of drug related mental health problems in Europe (Drugs and Psychosis and ISADORA Studies), Internet and drug addiction (Psychonaut 2002 study) amongst others. He is Director for the Centre of Addiction Research and Education Scotland (CARES) which is based at Ninewells Hospital Medical School . Dr Baldacchino is also NHS Fife Research and Development Director. Dr Kidd is a front line Consultant Psychiatrist who has been working in the addictions field for 15 years. He is Lead Clinician for the NHS Tayside Substance Misuse Services and is Senior Lecturer in Addiction Psychiatry in the Centre for Addiction Research & Education Scotland (CARES) in the University of Dundee Medical School with a key research interest in development of outcome measurement. Dr Kidd regularly advises government on treatment aspects of drug policy. He has been a member of the Scottish Advisory Committee on drug Misuse since 1998 and has been involved in key SACDM work-groups reporting on drug-related deaths, risks to children of drug-using parents and integration of services. He chaired the working groups producing the recent methadone review and ‘Essential Care’ reports on treatment services in Scotland in 2007/8. He represented Scottish psychiatric specialist opinion on the group developing the 2007 UK treatment guidelines and participated in the UKDPC consensus development group on recovery in 2008. Dr Kidd is also Chair of the Dundee City Drug & Alcohol Action Team and was deputy Chair of the Scottish Association of Drug & Alcohol Action Teams from 2005-8.